Swedish Orphan Biovitrum Ab (BIOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 416,902 | 278,562 | 329,111 | 384,197 | 353,705 |
| Depreciation Amortization | 348,033 | 301,760 | 239,723 | 233,900 | 220,507 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | -16,677 |
| Other Working Capital | -17,028 | -109,388 | -79,875 | 129,892 | -20,056 |
| Other Operating Activity | -49,003 | -49,413 | -26,658 | -110,187 | 30,847 |
| Operating Cash Flow | $698,905 | $421,521 | $462,302 | $637,802 | $568,326 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -16,082 | -38,380 | -7,135 | -5,130 | -3,597 |
| Net Acquisitions | N/A | -1,599,422 | N/A | N/A | N/A |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -13,080 |
| Purchase Sale Intangibles | -268,191 | -427,745 | -139,236 | -37,662 | -415,399 |
| Other Investing Activity | -276,327 | -427,745 | -139,236 | -37,662 | -415,399 |
| Investing Cash Flow | $-292,409 | $-2,065,547 | $-146,371 | $-42,792 | $-432,076 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,345,212 | 3,383,107 | 1,355,193 | 1,654,904 | 1,479,675 |
| Debt Repayment | -1,764,858 | -2,322,420 | -1,594,915 | -2,121,071 | -1,637,943 |
| Common Stock Issued | 40,394 | 17,068 | N/A | N/A | N/A |
| Other Financing Activity | 757 | 526,477 | -56,686 | -55,501 | -12,862 |
| Financing Cash Flow | $-378,495 | $1,604,232 | $-296,408 | $-521,668 | $-171,130 |
| Exchange Rate Effect | -5,771 | -3,301 | 11,793 | 1,399 | -1,417 |
| Beginning Cash Position | 85,518 | 128,342 | 103,560 | 47,106 | 80,333 |
| End Cash Position | 107,844 | 85,247 | 134,875 | 121,847 | 44,036 |
| Net Cash Flow | $22,326 | $-43,095 | $31,316 | $74,741 | $-36,297 |
| Free Cash Flow | |||||
| Operating Cash Flow | 698,905 | 421,521 | 462,302 | 637,802 | 568,326 |
| Capital Expenditure | -16,082 | -38,380 | -7,135 | -5,480 | -4,469 |
| Free Cash Flow | 682,823 | 383,141 | 455,166 | 632,322 | 563,857 |